Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 5386 AL 5400

Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection

Singh M, Kaur M, Kukreja H, Chugh R, Silakari O, Singh D.

Eur J Med Chem. 2013;70:165-88. doi: 10.1016/j.ejmech.2013.09.050. Epub 2013 Oct 6.

The therapeutic effects of human adipose-derived stem cells in Alzheimer's disease mouse models

Chang KA, Kim HJ, Joo Y, Ha S, Suh YH.

Neurodegener Dis. 2014;13(2-3):99-102. doi: 10.1159/000355261. Epub 2013 Oct 23.

Cost analysis of early psychosocial intervention in Alzheimer's disease

Søgaard R, Sørensen J, Waldorff FB, Eckermann A, Buss DV, Waldemar G.

Dement Geriatr Cogn Disord. 2014;37(3-4):141-53. doi: 10.1159/000355368. Epub 2013 Oct 19.

[Towards a vaccine against Alzheimer's?]

Dodel R.

Drug Res (Stuttg). 2013 Nov;63 Suppl 1:S18-20. doi: 10.1055/s-0033-1346715. Epub 2013 Nov 15.

Effect of donepezil in Alzheimer disease can be measured by a computerized human analog of the Morris water maze

Hort J, Andel R, Mokrisova I, Gazova I, Amlerova J, Valis M, Coulson EJ, Harrison J, Windisch M, Laczó J.

Neurodegener Dis. 2014;13(2-3):192-6. doi: 10.1159/000355517. Epub 2013 Oct 30.

Tacrine-flurbiprofen hybrids as multifunctional drug candidates for the treatment of Alzheimer's disease

Chen Y, Sun J, Peng S, Liao H, Zhang Y, Lehmann J.

Arch Pharm (Weinheim). 2013 Dec;346(12):865-71. doi: 10.1002/ardp.201300074. Epub 2013 Nov 6.

Why Alzheimer trials fail: removing soluble oligomeric beta amyloid is essential, inconsistent, and difficult

Rosenblum WI.

Neurobiol Aging. 2014 May;35(5):969-74. doi: 10.1016/j.neurobiolaging.2013.10.085. Epub 2013 Oct 19.

Effect and mechanism of acupuncture on Alzheimer's disease

Zeng BY, Salvage S, Jenner P.

Int Rev Neurobiol. 2013;111:181-95. doi: 10.1016/B978-0-12-411545-3.00009-2.

Alzheimer disease therapy--moving from amyloid-β to tau

Giacobini E, Gold G.

Nat Rev Neurol. 2013 Dec;9(12):677-86. doi: 10.1038/nrneurol.2013.223. Epub 2013 Nov 12.

Statins more than cholesterol lowering agents in Alzheimer disease: their pleiotropic functions as potential therapeutic targets

Barone E, Di Domenico F, Butterfield DA.

Biochem Pharmacol. 2014 Apr 15;88(4):605-16. doi: 10.1016/j.bcp.2013.10.030. Epub 2013 Nov 11.

Natural products for Alzheimer's disease therapy: basic and application

Xiao J, Tundis R.

J Pharm Pharmacol. 2013 Dec;65(12):1679-80. doi: 10.1111/jphp.12186.

Nature as a source of metabolites with cholinesterase-inhibitory activity: an approach to Alzheimer's disease treatment

Pinho BR, Ferreres F, Valentão P, Andrade PB.

J Pharm Pharmacol. 2013 Dec;65(12):1681-700. doi: 10.1111/jphp.12081. Epub 2013 May 16.

Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease

Konrath EL, Passos Cdos S, Klein LC Jr, Henriques AT.

J Pharm Pharmacol. 2013 Dec;65(12):1701-25. doi: 10.1111/jphp.12090. Epub 2013 Jun 20.

Berberis aetnensis and B. libanotica: a comparative study on the chemical composition, inhibitory effect on key enzymes linked to Alzheimer's disease and antioxidant activity

Bonesi M, Loizzo MR, Conforti F, Passalacqua NG, Saab A, Menichini F, Tundis R.

J Pharm Pharmacol. 2013 Dec;65(12):1726-35. doi: 10.1111/jphp.12172. Epub 2013 Nov 6.

Phase II crossover trial of varenicline in mild-to-moderate Alzheimer's disease

Kim SY, Choi SH, Rollema H, Schwam EM, McRae T, Dubrava S, Jacobsen J.

Dement Geriatr Cogn Disord. 2014;37(3-4):232-45. doi: 10.1159/000355373. Epub 2013 Nov 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias